Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire
Recruiting
N/A
Interventional Study
Endometrial Cancer
Lynch Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 30 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 30 (estimated)
- Sponsor
- University of British Columbia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to find out if self-collected vaginal swabs can be used to detect early signs of uterine cancer or related conditions in people with Lynch syndrome (LS) who still have their uterus. The study also tests if people with LS are willing and able to collect these samples themselves and whether they find the process acceptable.
The main questions this study asks are:
* Will p…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosed with Lynch syndrome (confirmed by genetic testing).
* Have an intact uterus.
* Age 30 years or older.
Exclusion Criteria:
* History of endometrial cancer or endometrial hyperplasia.
* History of pelvic radiation or endometrial ablation.
* Pregnant at the time of st…
Contacts
Research Assistant
604-875-4111
CONTACT